关键词:
  首页 > 美迪医讯 > FlowMedica公司开发出防止肾功能不全的设备  

FlowMedica公司开发出防止肾功能不全的设备

【 2005-07-29 发布 】 美迪医讯
美迪网领先的医疗器械电子商务平台


 
一种新型设备被设计用于防止充血性心衰患者在接受冠状动脉手术的时候出现肾功能不全。

慢性肾脏疾病合并充血性心衰会增加由于血管造影术中使用的染料或者支架手术时候发生肾脏功能衰竭的危险。这套Benephit Delta系统是以导管为基础的医疗设备,能够将特定药物和其它治疗药物直接输送到肾动脉。系统能够对两根肾动脉同时进行选择性给药,而只需使用一根导管。设计这套系统的主要目的是进行靶向肾脏治疗,作为系统性静脉注射药物治疗充血性心衰相关肾脏功能不全的替代选择。

近期在美国NewYork-Presbyterian医院一例男性患者中进行了这种操作程序,该患者当时接受血管扩张手术以治疗冠状动脉重度阻塞。在他的冠状动脉中放置了5个支架,这需要使用大剂量的染料。手术中使用Benephit Delta系统将一种药物 (非诺多泮)通过肾脏动脉直接输送到患者的肾脏,以增加血流量。患者没有出现危及生命的放射造影剂肾病。心血管医生估计大约有20%接受冠状动脉干预手术的患者能够从对放射造影剂肾病的治疗中获益。

Benefit Delta系统是由美国FlowMedica公司研制开发的,这是一家医疗设备公司。

Device Helps Prevent Kidney Dysfunction
 
A new device is designed to help prevent kidney dysfunction in patients with congestive heart failure (CHF) while undergoing coronary procedures.

The combination of chronic kidney disease and CHF greatly increases a patient’s risk of developing kidney failure from the dye used during an angiography or stenting procedure. The Benephit Delta system is a catheter-based medical device that enables the administration of specified medications and other therapeutic agents directly to the renal arteries. The system can provide selective infusion to both renal arteries simultaneously, using a single catheter. It is designed to provide targeted renal therapy (TRT), an alternative to systemic intravenous infusion of medications to treat kidney dysfunction related to CHF.

The procedure was recently used on a male patient at NewYork-Presbyterian Hospital (NY, USA) who had recently had angioplasty to treat two severely blocked coronary arteries. Five stents were placed in his coronary arteries, which required large amounts of dye. The Benephit Delta system was used to deliver a medication (fenoldopam) directly into the patient’s kidneys through the renal arteries to increase blood flow. The patient did not develop the potentially life-threatening condition known as radiocontrast nephropathy (RCN). Cardiologists estimate that about 20% of patients undergoing coronary interventions could benefit from treatment for RCN.

The Benefit Delta system was developed by FlowMedica, a medical device company (Fremont, CA, USA).

/**/
收藏本文到: Google书签 Digg Live Bookmark Yahoo书签 Facebook 百度搜藏 新浪ViVi 365Key网摘 天极网摘 和讯网摘 POCO网摘 QQ书签

  《美迪医讯》欢迎您参与新闻投稿,业务咨询: 美迪医疗网业务咨询

我要评论:《FlowMedica公司开发出防止肾功能不全的设备》
匿名发表 我的名字: Email: 验证码: 点击可刷新
 
    

  更多关于 FlowMedica公司,肾功能不全  的新闻

合作支持:中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会
刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图
把美迪网放进收藏夹  把美迪医疗网介绍给我的朋友  给美迪医疗网留言
美迪医疗网广告业务联系:021-51601230 产品咨询业务联系:021-51601230 传真:021-56532303    美迪医疗网业务咨询
互联网药品信息服务许可证:(沪)-经营性-2009-0003   中华人民共和国电信与信息服务业务经营许可证:(沪)B2-20090029 沪ICP备14001091号-8
 
公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号
营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081
消防排烟风机 华创商务网
美迪医疗网广告业务联系:021-51601230  产品咨询业务联系:021-51601230 传真:021-56532303   美迪医疗网产品咨询 本QQ仅咨询广告和会员业务,不咨询产品和药品等业务美迪医疗网推广业务咨询